J. Grunewald (Stockholm, Sweden), R. M. du Bois (London, United Kingdom)
Immunophenotyping and genic re-arrangement analysis in lymphocytic/lymphoproliferative disorders of the lungs
A. Ab‘Saber, C. Ishikawa, E. Parra, C. Lin, C. Valente Barbas, V. Capelozzi (São Paulo, Brazil)
|    |
Cytochrome P450 pharmacogenetics: a possible predictor of pulmonary drug induced toxicity?
M. Drent, P. Wijnen, P. Kuijpers, G. Koek, C. Neef, R. Op den Buijsch, A. Bast, O. Bekers (Maastricht, Netherlands)
| |
Accelerated variant of idiopathic pulmonary fibrosis: clinical and molecular behaviour
M. Selman, G. Carrillo, A. Estrada, M. Mejia, M. Gaxiola, C. Navarro, R. Perez-Padilla, T. King, A. Pardo, N. Kaminski (Mexico, DF, Mexico; San Francisco, CA, Pittsburgh, PA, United States Of America)
| |
Matrix metalloproteinases (MMPs), tissue inhibitor of matrix metalloproteinases (TIMPs) and transforming growth factor-β (TGFβ) expression in small airways (SA) of usual idiopathic pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hip
G. Mello, M. Dolhnikoff, R. Kairalla, C. Carvalho, P. Saldiva, T. Mauad (Sao Paulo, Brazil)
| |
Expression of claudins 1, 2, 3, 4, 5 and 7 in usual interstitial pneumonia and sarcoidosis
R. Kaarteenaho-Wiik, Y. Soini (Oulu, Finland)
| |
Idiopathic pulmonary fibrosis in relation to the gene polymorphisms of transforming growth factor-beta1 and plasminogen activation inhibitor 1
X. Li, H. Dai, M. Zhu, B. Pang, L. Ma, C. Wang (Beijing, China)
| |
Markers of fibrosis and tissue destruction in usual interstitial pneumonia associated with pulmonary emphysema
P. Rogliani, M. Mura, P. Mattia, A. Ferlosio, G. Farinelli, S. Mariotta, P. Graziano, G. Pezzuto, A. Orlandi, C. Saltini (Rome, Italy)
| |
Cytokine gene polymorphisms and high resolution computed tomography score in idiopathic pulmonary fibrosis
M. Vasakova, I. Striz, J. Dutka, A. Slavcev, S. Jandova, L. Kolesar, J. Sulc (Prague, Czech Republic)
| |